From July 1, 2023 to September 21, 2023, the company has repurchased 8,348 shares, representing 0.03% for CAD 0.12 million. With this, the company has completed the repurchase of 284,843 shares, representing 1.13% for CAD 1.03 million under the buyback announced on September 19, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 CAD | +1.52% | +2.47% | +57.22% |
Mar. 15 | Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024 | |
Mar. 14 | Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.22% | 150M | |
+31.37% | 699B | |
+25.07% | 571B | |
-4.34% | 364B | |
+18.33% | 326B | |
+2.84% | 286B | |
+14.36% | 236B | |
+4.45% | 198B | |
-12.31% | 194B | |
-4.24% | 154B |
- Stock Market
- Equities
- CPH Stock
- News Cipher Pharmaceuticals Inc.
- Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on September 19, 2022.